Wall Street Zen Upgrades ReposiTrak (NYSE:TRAK) to Buy

ReposiTrak (NYSE:TRAK) was upgraded by equities research analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a research note issued to investors on Saturday.

Separately, Weiss Ratings reissued a “hold (c+)” rating on shares of ReposiTrak in a report on Monday. One investment analyst has rated the stock with a Hold rating, According to data from MarketBeat, the stock presently has a consensus rating of “Hold”.

ReposiTrak Trading Down 2.7%

NYSE TRAK opened at $13.42 on Friday. ReposiTrak has a 1-year low of $12.75 and a 1-year high of $25.01. The company has a market capitalization of $245.45 million, a price-to-earnings ratio of 37.28 and a beta of 0.39. The stock’s 50 day moving average is $14.39 and its two-hundred day moving average is $16.90.

ReposiTrak (NYSE:TRAK) last posted its earnings results on Thursday, November 13th. The company reported $0.09 EPS for the quarter. The business had revenue of $5.97 million during the quarter. ReposiTrak had a return on equity of 14.37% and a net margin of 30.52%.

Insider Transactions at ReposiTrak

In other ReposiTrak news, CEO Randall K. Fields sold 7,500 shares of the business’s stock in a transaction on Monday, October 20th. The stock was sold at an average price of $15.47, for a total value of $116,025.00. Following the transaction, the chief executive officer owned 35,000 shares of the company’s stock, valued at approximately $541,450. The trade was a 17.65% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. In the last ninety days, insiders sold 89,500 shares of company stock valued at $1,340,230. Insiders own 41.00% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the business. BNP Paribas Financial Markets lifted its position in ReposiTrak by 63.5% during the 2nd quarter. BNP Paribas Financial Markets now owns 1,633 shares of the company’s stock worth $32,000 after buying an additional 634 shares in the last quarter. Ingalls & Snyder LLC raised its stake in shares of ReposiTrak by 1.3% in the second quarter. Ingalls & Snyder LLC now owns 198,714 shares of the company’s stock worth $3,905,000 after acquiring an additional 2,554 shares during the last quarter. Tower Research Capital LLC TRC lifted its position in shares of ReposiTrak by 397.3% during the second quarter. Tower Research Capital LLC TRC now owns 3,620 shares of the company’s stock worth $71,000 after purchasing an additional 2,892 shares in the last quarter. Ellsworth Advisors LLC grew its stake in shares of ReposiTrak by 10.6% during the first quarter. Ellsworth Advisors LLC now owns 31,289 shares of the company’s stock valued at $634,000 after purchasing an additional 2,997 shares during the last quarter. Finally, Raymond James Financial Inc. increased its holdings in shares of ReposiTrak by 22.5% in the third quarter. Raymond James Financial Inc. now owns 17,359 shares of the company’s stock valued at $257,000 after purchasing an additional 3,185 shares in the last quarter. 27.35% of the stock is owned by institutional investors.

ReposiTrak Company Profile

Park City Group, Inc, a software-as-a-service provider, designs, develops, and markets proprietary software products in North America. The company offers ReposiTrak MarketPlace, a supplier discovery and B2B e-commerce solution; ReposiTrak Compliance and Food Safety solutions, which reduces potential regulatory and legal risk from their supply chain partners; and ReposiTrak Supply Chain solutions that enables customers to manage relationships with suppliers.